Trials / Recruiting
RecruitingNCT07022470
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
Brachytherapy Fractionation Individualized by Treatment Feasibility in Cervical Cancer: Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 41 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 3-Fraction HDR Brachytherapy | 8 Gy per fraction for 3 fractions (total 24 Gy) for patients with locally advanced cervical cancer, based on individualized planning. |
| RADIATION | 4-Fraction HDR Brachytherapy | 7 Gy per fraction for 4 fractions (total 28 Gy) as the standard-of-care brachytherapy regimen. |
Timeline
- Start date
- 2025-06-03
- Primary completion
- 2028-06-01
- Completion
- 2028-06-01
- First posted
- 2025-06-15
- Last updated
- 2025-06-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07022470. Inclusion in this directory is not an endorsement.